ACTA1 and pulmonary fibrosis: Furthermore, administration of ICI-118,551 dramatically reduced bleomycin-induced lung fibrosis as demonstrated by H&E, Masson’s staining and immunohistochemical analysis of α-SMA (Fig. 2E).